Rubicon Genomics, Inc., Ann Arbor, MI. Reference provides a global overview of emerging drug discovery technologies. Presents new techniques from the disciplines of chemistry, biology, and computational sciences. Explains the rationale and developmental background behind evolving practices and highlights the impact of information technology on drug discovery.